Meditor Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-210,000
Closed -$12.9M 35
2013
Q3
$12.9M Buy
210,000
+20,000
+11% +$1.23M 1.82% 21
2013
Q2
$11.1M Buy
+190,000
New +$11.1M 1.5% 20